Home › Funds › Hemenway Trust Co LLC › ABT

Hemenway Trust Co LLC position in ABT

ABBOTT LABORATORIES · Health Care

Hemenway Trust Co LLC reported holding 345,119 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$34.1M, representing 2.52% of its reported portfolio and ranking #18 among its reported holdings. Hemenway Trust Co LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)345.12K sh
Reported value held$34.11M
Portfolio Weight2.52%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hemenway Trust Co LLC's ABT position evolved

Hemenway Trust Co LLC first disclosed a stake in ABT in Q3 2023 at 316,907 shares (US$30.7M). The position peaked in Q1 2025 at 372,188 shares, worth US$49.4M. Across 13 filings, Hemenway Trust Co LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 345,119 shares valued at US$34.1M — a reduction of -3,659 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 316.91K $30.69M New
Q4 2023 334.49K $36.82M Add
Q1 2024 342.96K $38.98M Add
Q2 2024 345.32K $35.88M Add
Q3 2024 349.61K $39.86M Add
Q4 2024 357.41K $40.43M Add
Q1 2025 372.19K $49.37M Add
Q2 2025 353.10K $48.03M Reduce
Q3 2025 342.01K $45.81M Reduce
Q4 2025 336.84K $42.20M Reduce
Q1 2026 337.73K $34.67M Hold
Q2 2026 348.78K $31.65M Add
Q3 2026 345.12K $34.11M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Hemenway Trust Co LLC held ABT?

Hemenway Trust Co LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Hemenway Trust Co LLC's current position in ABT?

As of Q3 2026, Hemenway Trust Co LLC holds 345.12K shares of ABT (ABBOTT LABORATORIES), valued at $34.11M, representing 2.52% of its reported portfolio and ranking #18.

Has Hemenway Trust Co LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Hemenway Trust Co LLC reduced its position in ABT. The position peaked in Q1 2025 at 372.19K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.